Search
for
Sort by
Research 721–750 of 1000+
- Dermatolojik Problemler ve COVID-19
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Prevalence of hair loss in Egyptian people after covid -19 vaccination.
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- A comment on psychological distress and women’s hair loss related to the COVID-19 pandemic
- Scalp capillarectasia as a trichoscopic sign of COVID‐19‐associated telogen effluvium
- Skin Diseases Associated With COVID-19: A Narrative Review
- The debut of systemic lupus erythematosus after suffering COVID-19 = Дебют системного червоного вовчака після перенесеного COVID-19
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- The Effect of Ferritin, Vitamin D, and Some Hormonal and Biochemical Parameters on Patients with Female-pattern Hair Loss after COVID-19 Infection
- Acute Telogen Effluvium: A Post-COVID-19 Sequela
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Hormones and COVID-19
- Commonalities Between COVID-19 and Radiation Injury
- Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- Contributions of dermatologists to COVID ‐19 research: A brief systematic review
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Impact of COVID-19 pandemic among healthcare professionals
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- ARTIFICIAL INTELLIGENCE TECHNIQUES IN PREDICTION OF COVID-19 MORTALITY AND ITS RELATED FACTORS: A MULTI-CENTER STUDY
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- A Systematic Review and Quality Evaluation of Studies on Long-Term Sequelae of COVID-19
- Analysing the patient experience of COVID‐19: Exploring patients' experiences of hospitalisation and their quality of life post discharge
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- New‐onset and exacerbated skin diseases after COVID‐19 infection: A systematic review